A cytokine storm is one of the leading causes of acute respiratory distress syndrome (ARDS)
and sepsis‐associated multiple organ failure in many respiratory viral infections, including …

The emergency of the coronavirus disease 2019 (COVID-19) pandemic led to the off-label
use of drugs without data on their toxicity profiles in patients with COVID-19, or on their …

Abstract SARS-coronavirus 2 (SARS-CoV-2), the etiologic agent of the new lung disease
COVID-19 is closely related to SARS-CoV, and together with MERS-CoV are three new …

Background: Postacute sequelae of severe acute respiratory syndrome coronavirus 2
infection (PASC), or long-COVID, are signs and symptoms that persist after the acute phase …

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) belonging to genus
beta-coronavirus has been associated with an acute respiratory disease termed coronavirus …

Acute respiratory distress syndrome (ARDS) remains a serious illness with significant
morbidity and mortality, characterized by hypoxemic respiratory failure most commonly due …

Acute respiratory distress syndrome (ARDS) is a heterogeneous lung disease responsible
for significant morbidity and mortality among critically ill patients, including those infected …

The acute exudative phase of acute respiratory distress syndrome (ARDS), a severe form of
respiratory failure, is characterized by alveolar damage, pulmonary oedema, and an …

Background: It is imperative to identify drugs that allow treating symptoms of severe COVID-
19. Respiratory failure is the main cause of death in severe COVID-19 patients, and the host …

There is an urgent need to identify effective strategies that can stop or reverse the
inflammatory process that causes acute lung injury, ARDS, and multi-organ failure in COVID …